HomeFUNDING

Category: FUNDING

Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.

Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.

Vitestro Secures $22 Million (€20...

April 30, 2024

Co-led by return investor Sonder Capital and new investor NYBC Ventures, with participation from Invest-NL, the European Innovation Council Fund (EIC Fund), and existing private investors, the oversubscribed funding round will support Vitestro’s commercialization in Europe and its organizational expansion into the U.S. market.

E Tech Group Secures New...

April 11, 2024

With this new investment partnership, E Tech Group expects to accelerate organic growth and acquisition to become a top system integrator in North America.

Vitestro Secures $22 Million (€20 million) for Autonomous Blood Draw Device

April 30, 2024

Promaxo Raises $4.17M – To Accelerate Data Strategy

Funds will help accelerate its data strategy as it continues to incorporate artificial intelligence in imaging and image-based interventions.

January 13, 2021

Runway Growth Capital Announces a Senior Secured Term Loan of $50 Million to VERO Biotech

Runway Growth Capital, in the past two quarters, has announced the closing of three life sciences sector deals totaling $130 million in aggregate; VERO Biotech joins Gynesonics and Intact Vascular in Runway's life sciences portfolio.

January 12, 2021

Noctrix Health, Inc. Completes $17M Series B Financing

The financing was co-led by Treo Ventures and OrbiMed, with participation from LivaNova PLC (NASDAQ: LIVN) and other insiders.

January 11, 2021

InterShunt Technologies Announces Equity Financing

Funding will be used to support the research and development of the Percutaneous Atrial Shunt Catheter System.

January 11, 2021

Neuros Medical Raises $38.5M in Series BB: Funds Enable Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain

The financing provides capital to complete enrollment of the pivotal QUEST (High-FreQUEncy Nerve Block for PoST-Amputation Pain) study, and to submit an anticipated application for Pre-Market Approval. QUEST is a 180-subject, randomized, double-blinded, active sham-controlled clinical trial that is being conducted under an Investigational Device Exemption

January 7, 2021

Volta Medical Raises $28 Million: To Establish its FDA-cleared and CE marked VX1 AI Software Solution As a New Standard of Care

Volta Medical advises that the financing round was led by Gilde Healthcare with the participation of existing shareholder Pasteur Mutualité.

January 5, 2021

Emboline Raises Over $10 Million in Series C Funding: Funds Raised To Be Used to Obtain Initial Commercial Approval of the Emboliner & Launch of a US IDE Clinical Study

xEmboline recently completed the 3-center, 31-patient SafePass 2 study of the Emboliner™ in New Zealand in which the device met all primary endpoints for safety and technical performance when used during TAVR.

January 5, 2021

Fujifilm to invest $40 Million to Establish a New State-of-the-Art Viral Vector and Advanced Therapy Process Development and Manufacturing Facility

Fujifilm notes the new facility is scheduled to begin process development operations in fall 2021.

January 4, 2021

Ensysce Biosciences Secures $60 Million Capital Commitment From Global Emerging Markets

Ensyce Biosciences notes under the accord, GEM agrees to provide Ensysce with a share subscription facility of up to $60 million for a 36-month term following the public listing of the Company's common stock.

December 31, 2020